Global acceptance and hesitancy of COVID-19 vaccination: A narrative review

86Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization and has disrupted many aspects of the community around the globe. Vaccination is one of the prominent measures to control the COVID-19 pandemic. More than 120 vaccines have entered human clinical trials and at least 8 vaccines have been fully approved. However, the success of the COVID-19 vaccination programs depends on how the community accepts the vaccines. Despite COVID-19 vaccination having been initiated for a while now, more than 50% of the global population have not been vaccinated. In some low- and middle-income countries (LMICs), the vaccine coverage is less than 20%. Since the decision to accept the new vaccine is complex, understanding the factors underpinning vaccine acceptance is critical. This review aimed to summarize the COVID-19 vaccine acceptance rate around the globe as well as its associated determinants. Information from this study might be important to formulate effective strategies to increase the COVID-19 vaccine coverage, and to be able to achieve herd immunity.

Cite

CITATION STYLE

APA

Hassan, W., Kazmi, S. K., Tahir, M. J., Ullah, I., Royan, H. A., Fahriani, M., … Rosa, S. G. V. (2021, December 1). Global acceptance and hesitancy of COVID-19 vaccination: A narrative review. Narra J. Narra Sains Indonesia. https://doi.org/10.52225/narra.v1i3.57

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free